Tag: Hatch-Waxman
Pediatric Exclusivity: How the FDA Extends Market Protection for Drug Companies
Pediatric exclusivity gives drug companies six extra months of market protection after they study their medicines in children. It doesn't extend patents but blocks generic approval, making it a powerful tool in pharmaceutical strategy.